Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

UPDATE Exposed: Aeras’ Upcoming Film Series on Tuberculosis

exposed

Release of Part 1 of EXPOSED scheduled for the week of May 20. EXPOSED is a four-part series of short films that tell the story of the deadly global epidemic of tuberculosis. The series will portray the struggles of four inspiring individuals – an MDR-TB survivor, a TB doctor, a clinical trial volunteer, and a TB vaccine researcher – bringing viewers to the forefront of the race against tuberculosis.

13 Dec 2012

Multidrug-Resistance Tuberculosis: No Promises

MSF video

A video from Medecins Sans Frontieres entitled “Multidrug-Resistance Tuberculosis: No Promises” on the situation of children affected with MDR-TB. It highlights the dire plight of children being treated for MDR-TB in Tajikistan.

The Growing Landscape of TB Trials: Interview with Dr. Andrew Vernon

thumb206-andy

This week we highlight an interview with Dr. Andrew Vernon, the Chief, Clinical Research Branch, Division of Tuberculosis Elimination at the U.S. Centers for Disease Control and Prevention (CDC). He discusses the progress made in TB drug development and the growing number of TB trials and trials groups.

29 Aug 2012

Live Streaming of Demystifying Pyrazinamide Workshop–September 5 & 6

Pyrazinamide_Structure

On September 5 and 6, 2012, the “Demystifying Pyrazinamide – Challenges and Opportunities” Workshop will be held at Johns Hopkins University and is sponsored by National Institute of Allergy and Infectious Diseases, Bill and Melinda Gates Foundation, Johns Hopkins University Center for AIDS Research, and the Stop TB Partnership Working Group on New Drugs. There will be live streaming available.

24 Jul 2012
by Working Group

Posted in Announcements, TB Drug Development, TB News, Video

TB R&D Weekly Update: Results from First Novel Regimen Trial Published

novel regimen video

Yesterday, efficacy data from the first novel regimen trial (NC001) were published in the Lancet. The results found that the regimen containing PA-824, moxifloxacin, and pyrazinamide, could kill more than 99 percent of patients’ TB bacteria within two weeks and could be more effective than existing treatments. Link to article, press release, and related video are included. Additional links to TB R&D news are also included.

InTB Winners Announced!

InTB Winners Logo

The inaugural InTB contest winners are announced in three categories: Overall Winner, Advocacy Winner, and Fan Favorite. Thank you to all entrants. Keep submitting your innovations to grow the InTB library!

Integrating TB and HIV Services at the Community Level

jeannine

This week we highlight an interview with Jeannine Uwimana, a public health specialist from the University of the Western Cape and TB/HIV Care Association in South Africa. She discusses her work in developing models for community-based programs to enhance TB and HIV collaborative activities.

Kick TB Campaign: Scoring Big in South Africa and Beyond

soccerballFront-300x290

The Kick TB Campaign is a unique project that uses the World’s most popular sport to educate and engage young people in the effort to stop the spread of tuberculosis (TB).

21 Jul 2011

Interview with TB Alert’s Mike Mandelbaum

Mike Mandelbaum, Chief Executive, TB Alert

Mike Mandelbaum is Chief Executive of TB Alert, which is the UK’s National and International Tuberculosis charity – the only British charity working solely on fighting TB in the UK and overseas.

Video: Jenniffer Dietrich, Challenge Facility for Civil Society

Jenniffer Dietrich, Stop TB Partnership

Jenniffer Dietrich is Technical Officer at the Challenge Facility for Civil Society of the Stop TB Partnership.